Agile Therapeutics(AGRX)

0.3400 -0.0300 -8.11%

今开:0.333昨收:0.37
最高:0.405 最低:0.313
涨停价:0.0跌停价:0.0
总市值:1007643.0

Agile Therapeutics的热门讨论

当期报告

Agile Therapeutics(AGRX)03-28 21:15

$Agile Therapeutics(AGRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-004174  Act: 34  Size: 503 KB 网页链接查看全文

年度财报

Agile Therapeutics(AGRX)今天 05:05

$Agile Therapeutics(AGRX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-004262  Act: 34  Size: 10 MB 网页链接查看全文

当期报告

Agile Therapeutics(AGRX)03-26 04:35

$Agile Therapeutics(AGRX)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001558370-24-003854  Act: 34  Size: 207 KB 网页链接查看全文

当期报告

Agile Therapeutics(AGRX)03-15 04:55

$Agile Therapeutics(AGRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001558370-24-003246  Act: 34  Size: 192 KB 网页链接查看全文

当期报告

Agile Therapeutics(AGRX)02-24 05:45

$Agile Therapeutics(AGRX)$ 8-K Current report, items 1.01, 3.02, 3.03, 8.01, and 9.01 Accession Number: 0001558370-24-001624  Act: 34  Size: 803 KB 网页链接查看全文

招股说明书

Agile Therapeutics(AGRX)02-24 06:05

$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-027083  Act: 33  Size: 22 KB 网页链接查看全文

招股说明书

Agile Therapeutics(AGRX)02-24 06:05

$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-027084  Act: 33  Size: 21 KB 网页链接查看全文

当期报告

Agile Therapeutics(AGRX)02-16 05:55

$Agile Therapeutics(AGRX)$ 8-K Current report, items 1.01, 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-001247  Act: 34  Size: 250 KB 网页链接查看全文

超过5%股东持股披露「修订」

Agile Therapeutics(AGRX)02-14 09:05

$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000556  Act: 34  Size: 76 KB 网页链接查看全文

招股说明书「补充」

Agile Therapeutics(AGRX)02-05 22:25

$Agile Therapeutics(AGRX)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-24-010379  Act: 33  Size: 915 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48

Agile Therapeutics的最新讨论

逍遥投资派2023-05-13 19:38

$Agile Therapeutics(AGRX)$ 2020年产生少量营收,2022年增长到1100万,营业利润和净利润继续大幅亏损,目前缺乏投资价值。查看全文

反贾骗联盟首席2022-07-11 14:34

$Agile Therapeutics(AGRX)$ $Evofem Biosciences(EVFM)$ 这两个标的一起来看,信息比较稀少,需要仔细看IR和SEC的内容,方向了解还比较少,是个新的有潜力的细分方向查看全文

David_51982021-02-10 02:16

$Agile Therapeutics(AGRX)$ 女性避孕贴,图形漂亮[笑]查看全文

涅槃重生之银河2019-11-15 22:50

$Agile Therapeutics(AGRX)$ 好惨,幸亏昨晚遵循赌股不过夜的原则2.45跑了[鼓鼓掌][鼓鼓掌][鼓鼓掌]查看全文

郁闷的鞋套-2019-11-15 12:04

$Agile Therapeutics(AGRX)$ FDA还能这么玩啊。。。。$阿玛琳(AMRN)$ 会不会有点瑟瑟发抖。。。查看全文

1 2 3 4 5 6 7 8 9

Agile Therapeutics的新闻

Agile Therapeutics盘前大涨35% 与VitaCare处方服务公司达成新协议

来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接

Agile Therapeutics的公告

$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-040984 Size: 64 KB 网页链接

$Agile Therapeutics(AGRX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0001037389-19-000003 Size: 13 KB 网页链接

$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-02-11 AccNo: 0001104659-19-007141 Size: 78 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Agile Therapeutics(AGRX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-01-23 AccNo: 0001047469-19-000195 Size: 351 KB 网页链接

$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-01-23 AccNo: 0001104659-19-002849 Size: 282 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-01-10 AccNo: 0001104659-19-001481 Size: 48 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001104659-19-000994 Size: 2 MBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2019-01-03 AccNo: 0001104659-19-000502 Size: 23 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接

$Agile Therapeutics, Inc.(AGRX)$ 8-K - Current report Filed: 2018-12-13 AccNo: 0001104659-18-072839 Size: 43 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$Agile Therapeutics, Inc.(AGRX)$ EFFECT - Notice of Effectiveness Filed: 2018-11-14 AccNo: 9999999995-18-002891 Size: 1 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47